Cornerstone Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.47M | Sell |
12,912
-15,072
| -54% | -$7.24M | 0.21% | 104 |
|
|
2026
Q1 | $13.8M | Sell |
27,984
-29,116
| -51% | -$15.8M | 0.51% | 59 |
|
|
2025
Q4 | $33.1M | Hold |
57,100
| – | – | 1.1% | 17 |
|
|
2025
Q3 | $27.7M | Sell |
57,100
-600
| -1% | -$279K | 0.91% | 26 |
|
|
2025
Q2 | $23.4M | Buy |
57,700
+36,900
| +177% | +$15.4M | 0.8% | 29 |
|
|
2025
Q1 | $10.4M | Hold |
20,800
| – | – | 0.45% | 51 |
|
|
2024
Q4 | $10.8M | Buy |
20,800
+5,100
| +32% | +$2.8M | 0.43% | 50 |
|
|
2024
Q3 | $9.71M | Hold |
15,700
| – | – | 0.38% | 57 |
|
|
2024
Q2 | $8.68M | Sell |
15,700
-100
| -0.6% | -$57.3K | 0.35% | 65 |
|
|
2024
Q1 | $9.18M | Hold |
15,800
| – | – | 0.38% | 59 |
|
|
2023
Q4 | $8.39M | Sell |
15,800
-1,900
| -11% | -$920K | 0.37% | 70 |
|
|
2023
Q3 | $8.96M | Buy |
17,700
+300
| +2% | +$160K | 0.42% | 58 |
|
|
2023
Q2 | $9.08M | Buy |
17,400
+10,000
| +135% | +$5.4M | 0.43% | 62 |
|
|
2023
Q1 | $4.27M | Hold |
7,400
| – | – | 0.2% | 111 |
|
|
2022
Q4 | $4.08M | Hold |
7,400
| – | – | 0.2% | 120 |
|
|
2022
Q3 | $3.75M | Sell |
7,400
-22,000
| -75% | -$12.3M | 0.18% | 126 |
|
|
2022
Q2 | $16M | Buy |
29,400
+7,400
| +34% | +$4.07M | 0.84% | 33 |
|
|
2022
Q1 | $13M | Hold |
22,000
| – | – | 0.77% | 30 |
|
|
2021
Q4 | $14.7M | Hold |
22,000
| – | – | 0.8% | 30 |
|
|
2021
Q3 | $12.6M | Sell |
22,000
-12,000
| -35% | -$6.59M | 0.73% | 37 |
|
|
2021
Q2 | $17.2M | Buy |
34,000
+4,000
| +13% | +$1.89M | 1.01% | 23 |
|
|
2021
Q1 | $13.7M | Hold |
30,000
| – | – | 1.2% | 18 |
|
|
2020
Q4 | $14M | Hold |
30,000
| – | – | 1.23% | 17 |
|
|
2020
Q3 | $13.2M | Hold |
30,000
| – | – | 1.19% | 17 |
|
|
2020
Q2 | $10.9M | Buy |
30,000
+8,000
| +36% | +$2.68M | 1.01% | 23 |
|
|
2020
Q1 | $6.24M | Hold |
22,000
| – | – | 0.69% | 38 |
|
|
2019
Q4 | $7.15M | Buy |
+22,000
| New | +$6.67M | 0.59% | 45 |
|
|
2019
Q1 | $6.02M | Hold |
22,000
| – | – | 0.49% | 58 |
|
|
2018
Q4 | $4.92M | Hold |
22,000
| – | – | 0.43% | 63 |
|
|
2018
Q3 | $5.37M | Hold |
22,000
| – | – | 0.39% | 72 |
|
|
2018
Q2 | $4.56M | Hold |
22,000
| – | – | 0.55% | 47 |
|
|
2018
Q1 | $4.54M | Hold |
22,000
| – | – | 0.54% | 56 |
|
|
2017
Q4 | $4.18M | Hold |
22,000
| – | – | 0.48% | 61 |
|
|
2017
Q3 | $4.16M | Buy |
22,000
+6,000
| +38% | +$1.09M | 0.48% | 58 |
|
|
2017
Q2 | $2.79M | Hold |
16,000
| – | – | 0.51% | 53 |
|
|
2017
Q1 | $2.46M | Hold |
16,000
| – | – | 0.44% | 70 |
|
|
2016
Q4 | $2.26M | Buy |
16,000
+2,000
| +14% | +$295K | 0.42% | 72 |
|
|
2016
Q3 | $2.23M | Hold |
14,000
| – | – | 0.57% | 50 |
|
|
2016
Q2 | $2.07M | Hold |
14,000
| – | – | 0.51% | 57 |
|
|
2016
Q1 | $1.98M | Hold |
14,000
| – | – | 0.48% | 64 |
|
|
2015
Q4 | $1.99M | Hold |
14,000
| – | – | 0.46% | 64 |
|
|
2015
Q3 | $1.71M | Buy |
14,000
+1,000
| +8% | +$130K | 0.4% | 69 |
|
|
2015
Q2 | $1.69M | Hold |
13,000
| – | – | 0.38% | 76 |
|
|
2015
Q1 | $1.75M | Hold |
13,000
| – | – | 0.36% | 74 |
|
|
2014
Q4 | $1.63M | Hold |
13,000
| – | – | 0.32% | 89 |
|
|
2014
Q3 | $1.58M | Hold |
13,000
| – | – | 0.31% | 93 |
|
|
2014
Q2 | $1.53M | Buy |
13,000
+5,000
| +63% | +$588K | 0.31% | 104 |
|
|
2014
Q1 | $962K | Buy |
8,000
+1,000
| +14% | +$119K | 0.23% | 132 |
|
|
2013
Q4 | $779K | Buy |
7,000
+4,000
| +133% | +$398K | 0.19% | 145 |
|
|
2013
Q3 | $276K | Buy |
+3,000
| New | +$271K | 0.09% | 202 |
|
Other funds holding TMO
Cornerstone Advisors's TMO Position: Q2 2026 in Review
Cornerstone Advisors reduced its Thermo Fisher Scientific (TMO) stake by 54% in Q2 2026, selling an estimated $7.24M and leaving 12,912 shares worth $6.47M. The position accounts for 0.21% of the portfolio, ranked #104.
Cornerstone Advisors first reported a position in TMO in Q3 2013 and has held it in 50 quarters since. The position peaked at $33.1M in Q4 2025. 1,696 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Cornerstone Advisors held 12,912 shares of Thermo Fisher Scientific worth $6.47M as of Q2 2026.
- Cornerstone Advisors sold 15,072 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.24M.
- Thermo Fisher Scientific made up 0.21% of Cornerstone Advisors's portfolio in Q2 2026, its #104 holding.
- Cornerstone Advisors first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 50 quarters since.
- Cornerstone Advisors's Thermo Fisher Scientific position peaked at $33.1M in Q4 2025.
- 1,696 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Cornerstone Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.